More about Jubilant Pharmova Limited
Fundamentals for Jubilant Pharmova Limited
Regulatory Filings for Jubilant Pharmova Limited
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
Technicals for Jubilant Pharmova Limited
Price Summary
Jubilant Pharmova Limited's stock began trading at 924.5 on 2026-04-30, soared to 935.5, dipped to 920.1, and finished the day 0.23% up at 926.6, with 64814 shares exchanged.Over the past year, the stock's highest price was 1236.3, and its lowest was 807.65.
Technicals
Support and Resistance: The current price of 926.6 for JUBLPHARMA finds support at 882.7 and resistance at 945.4. These levels define a range in which the price might oscillate, with 882.7 as a potential support and 945.4 as a resistance level.Aroon: The current state of the AROON is neutral for JUBLPHARMA, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
Bol. Bands: The BOLL BANDS is currently in a neutral position for Jubilant Pharmova Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
Parabolic SAR: The PSAR remains in a bearish mode, setting a strong resistance level that could impede any upward trends. This resistance indicates that the market may struggle to break higher, reflecting ongoing bearish sentiment for JUBLPHARMA.
Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for JUBLPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook